| Market Cap | 29.54M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -7.2M | Forward P/E | -0.23 | EPS next Y | - | 50D Avg Chg | -1.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -3.00% |
| Dividend | N/A | Price/Book | 0.75 | EPS next 5Y | - | 52W High Chg | -24.00% |
| Recommedations | - | Quick Ratio | 26.19 | Shares Outstanding | 1.21M | 52W Low Chg | 11.00% |
| Insider Own | 1.29% | ROA | -14.35% | Shares Float | 4.79M | Beta | 0.90 |
| Inst Own | 101.46% | ROE | -20.05% | Shares Shorted/Prior | 4.99M/4.23M | Price | 2.05 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 25,698 | Target Price | - |
| Oper. Margin | - | Earnings Date | Aug 1 | Volume | 9,555 | Change | 0.49% |
ARCA biopharma, Inc., a clinical stage biopharmaceutical company, engages in the development and commercialization of targeted therapies for cardiovascular diseases. Its lead product candidate is Gencaro, a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase IIb trial for the treatment of atrial fibrillation in patients with heart failure. It is developing Recombinant Nematode Anticoagulant Protein c2, a protein therapeutic that is in Phase IIb clinical trial for the treatment for COVID-19. The company has a collaboration agreement with LabCorp to develop genetic test for GENETIC-AF clinical trial. ARCA biopharma, Inc. is headquartered in Westminster, Colorado.
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Funicular Fund, LP | - - | May 23 | Buy | 2.3 | 85,262 | 196,103 | 2,580,452 | 05/25/22 |
| Funicular Fund, LP | - - | May 18 | Buy | 2.28 | 13,073 | 29,806 | 2,495,190 | 05/20/22 |
| Funicular Fund, LP | - - | May 12 | Buy | 2.29 | 84,836 | 194,274 | 2,482,117 | 05/16/22 |
| Funicular Fund, LP | - - | May 10 | Buy | 2.28 | 45,575 | 103,911 | 2,397,281 | 05/11/22 |
| Funicular Fund, LP | - - | May 05 | Buy | 2.28 | 124,122 | 282,998 | 2,351,706 | 05/09/22 |
| Funicular Fund, LP | - - | Apr 28 | Buy | 2.31 | 33,614 | 77,648 | 2,227,584 | 05/02/22 |
| Funicular Fund, LP | - - | Apr 25 | Buy | 2.2913 | 13,751 | 31,508 | 2,193,970 | 04/27/22 |
| Funicular Fund, LP | - - | Apr 18 | Buy | 2.3117 | 9,119 | 21,080 | 2,180,219 | 04/20/22 |
| Funicular Fund, LP | - - | Apr 14 | Buy | 2.3289 | 17,410 | 40,546 | 2,171,100 | 04/14/22 |
| Funicular Fund, LP | - - | Apr 08 | Buy | 2.32 | 104,713 | 242,934 | 2,153,690 | 04/12/22 |
| Funicular Fund, LP | - - | Apr 05 | Buy | 2.31 | 103,984 | 240,203 | 2,048,977 | 04/07/22 |
| Funicular Fund, LP | - - | Apr 01 | Buy | 2.2585 | 122,342 | 276,309 | 1,944,993 | 04/07/22 |